Guizhou Yibai Pharmaceutical Co.,Ltd.’s Net Profit Dropped 23.1% in First Half of 2022

Guizhou Yibai Pharmaceutical Co.,Ltd. (贵州益佰制药股份有限公司) (600594.SH) reported a net profit of 125.8 million yuan in the first half of 2022, down 23.1% year-on-year.

Meanwhile, the company posted 1.4 billion yuan in revenue, down 14.3% year-on-year.

At the end of the reporting period, it had 5.8 billion yuan in total assets and 2.1 billion yuan in total liabilities, with a liability-to-asset ratio of 36.8%.